We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Speaker; Dr. Carlos Briones, Laboratory of Molecular Evolution- Center for Astrobiology (CSIC-INTA, Associated with the NASA Astrobiology Program)
One of the main scientific questions is how life began on Earth... or perhaps on any other planet or satellite. The first scientific reflections on this subject were due to Charles R. Darwin, though the pioneering work in the field was the essay The Origin of Life, published by the Russian biochemist Alexandr I. Oparin in 1924. Since then, numerous theoretical and experimental advances have been made on the origin of life, showing how the basic monomers and biopolymers could have been synthesized under prebiotic conditions. Among the latter, ribonucleic acid (RNA) is particularly relevant, since in the origin of life it was able to function as genotype (molecule with heritable genetic information) and phenotype (thanks to its structural plasticity and functional versatility). During the last decades, experiments of in vitro evolution of RNA (and also of single-stranded DNA) are being carried out to obtain nucleic acids with specific binding capacity to any molecule of interest (called aptamers) or with catalytic activities (ribozymes). Aptamers are especially relevant in biotechnology and biomedicine, with applications in diagnostics and therapeutics. In particular, we are using them as molecular probes in nanobiosensors that allow the ultrasensitive detection of pathogenic viruses. All of these topics will be discussed in this talk.
Host: Dr. Josep Quer, Main researcher-Liver Diseases (VHIR)
Register here to attend by Zoom: https://gencat.zoom.us/j/82583647893
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.